Applications sought for Strategic Pharma-Academic Research Consortium
June 19, 2014
Researchers working in the area of autoimmune disease are sought for a new opportunity from the Strategic Pharma-Academic Research Consortium.
Established by the Indiana Clinical and Translational Sciences Institute, SPARC consists of partners from both academia and the pharmaceutical industry. Inaugural members are Indiana CTSI, Ohio State University, Northwestern University, Washington University in St. Louis, Eli Lilly and Co. and Takeda Pharmaceuticals, Inc.
This award will provide up to $400,000 over two years. Applicants must have at least two project-specific personnel from different participating academic member institutions.
Complete guidelines and application forms are available through the Indiana CTSI grants portal. Applicants may log in using their institutional username and password. (Applicant at eligible institutions who are not listed on the drop down menu may log in by creating an account with the Indiana CTSI using the instructions to the right of the login area.) Materials are accessible under "Strategic Pharma-Academic Research Consortium Awards Program - 2014.08 (SPARC)."
The deadline to submit a letter of intent is Tuesday, July 29. Complete proposals for selected applicants are due Tuesday, Sept. 23. The funding start date for successful applicants will be no earlier than Wednesday, Oct. 1, 2014.
For more information, contact Anne Nguyen at email@example.com.